UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033960
Receipt number R000038720
Scientific Title The photopic negative response in glaucoma and non-glaucoma: Effects of new stimulus conditions.
Date of disclosure of the study information 2021/03/31
Last modified on 2023/10/14 13:19:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The photopic negative response in glaucoma and non-glaucoma: Effects of new stimulus conditions.

Acronym

The photopic negative response in glaucoma and non-glaucoma: Effects of new stimulus conditions.

Scientific Title

The photopic negative response in glaucoma and non-glaucoma: Effects of new stimulus conditions.

Scientific Title:Acronym

The photopic negative response in glaucoma and non-glaucoma: Effects of new stimulus conditions.

Region

Japan


Condition

Condition

open angle glaucoma and non-glaucoma

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine the relationship between the morphology and function in the macular region of eyes with open angle glaucoma

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

electroretinogram

Key secondary outcomes

visual field
optical coherence tomography study


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Objects: The diagnosis of OAG was based on the presence of normal open angle and glaucomatous optic disc corresponding to glaucomatous visual field defect.
The inclusion criteria were as follows: a best-corrected visual acuity is more than 1.0. Exclusion criteria were as follows: intraocular abnormalities other than glaucoma,history of ocular surgeries including laser therapy.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.The patient who was enough explained and understand this study.

2.The patient who agree this study by the free will and sign consent forms.

3.The patient who was diagnosed adjuvant is appropriate.

Key exclusion criteria

The patient who judged adjuvant is inappropriate by principal investigator or member of a research project.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Kiyofumi
Middle name
Last name Mochizuki

Organization

Gifu University Graduate School of Medicine

Division name

Department of Ophthalmology

Zip code

501-1194

Address

1-1 Yanagido, Gifu-shi, Gifu

TEL

0582306283

Email

mochi-gif@umin.ac.jp


Public contact

Name of contact person

1st name Kiyofumi
Middle name
Last name Mochizuki

Organization

Gifu University

Division name

Department of Ophthalmology

Zip code

501-1194

Address

1-1 Yanagido, Gifu-shi, Gifu

TEL

0582306283

Homepage URL


Email

mochi-gif@umin.ac.jp


Sponsor or person

Institute

Gifu University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Gifu University Graduate School of Medicine Research Support Section

Address

1-1 Yanagido, Gifu-shi, Gifu

Tel

058-230-6059

Email

rinri@gifu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

ツカザキ病院(兵庫県)


Other administrative information

Date of disclosure of the study information

2021 Year 03 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications

none

Number of participants that the trial has enrolled


Results

This study has been terminated due to difficulties in enrolling new patients as a result of the coronavirus pandemic.

Results date posted

2023 Year 10 Month 14 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

none

Participant flow

none

Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2016 Year 04 Month 01 Day

Date of IRB

2021 Year 07 Month 30 Day

Anticipated trial start date

2016 Year 04 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry

2023 Year 03 Month 31 Day

Date trial data considered complete

2023 Year 03 Month 31 Day

Date analysis concluded

2023 Year 03 Month 31 Day


Other

Other related information

This study has been terminated due to difficulties in enrolling new patients as a result of the coronavirus pandemic.


Management information

Registered date

2018 Year 08 Month 30 Day

Last modified on

2023 Year 10 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038720


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name